ArticleFrontiers in pharmacology2022

Pancreatic Adverse Events Associated With Immune Checkpoint Inhibitors: A Large-Scale Pharmacovigilance Analysis.

Yue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.